Join to View Full Profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-606-7123
Dr. Cherian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematopathology, 2004 - 2005- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2001 - 2004
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2000 - 2001
Emory University School of MedicineClass of 2000
Certifications & Licensure
WA State Medical License 2005 - 2025
PA State Medical License 2001 - 2006
American Board of Pathology Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 2 citationsDose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.Noam E Kopmar, Kim Quach, Ted A Gooley, Christen H Martino, Sindhu Cherian
JAMA Oncology. 2024-07-01 - PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow...David M Dorfman, Katherine A Devitt, Wei Cui, Christine Bashleben, Elena C Frye Naharro
Archives of Pathology & Laboratory Medicine. 2024-06-01 - 4 citationsGenetics and pathologic landscape of lineage switch of acute leukemia during therapy.Ting Zhou, Choladda V Curry, Mahsa Khanlari, Min Shi, Wei Cui
Blood Cancer Journal. 2024-01-25
Lectures
- Factors Impacting Progression-Free Survival after CD19-Specific CAR-T Cell Therapy for Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
In Hematopathology, Online Learning Mirrors PracticeJuly 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
